Skip to content
Search

Latest Stories

As medicine shortages are found to be a Europe-wide problem, NPA calls for urgent action

Medicines shortages are a growing problem in the UK as well as across Europe, a recent survey has revealed.

According to a Pharmaceutical Group of European Union (PGEU) survey, pharmacy associations in most European countries admitted to having experienced medicine shortages in 2019, while 92 per cent of the countries reported shortages affecting patient's trust in community pharmacies.


In the majority of responding countries, over 200 medicines were listed as being in short supply and pharmacy staff were said to be spending an average of six hours per week on dealing with shortages.

The survey also identified a gap in information, tools and legal solution to community pharmacists in many European countries for providing the solution to patients in case of a shortage.

“All responding countries indicated that they believe medicine shortages caused distress and inconvenience to patients,” it further revealed.

NPA CALLS FOR URGENT ACTION

Commenting on the survey, the National Pharmacy Association (NPA) called for urgent action and said the data was further evidence of a widespread problem in the UK and across Europe.

“Because of heroic efforts by pharmacists, patients usually get their medicines when and where they need them, but longstanding faults in the medicines supply chain too often leave patients waiting. It’s time for urgent action, to reduce the risk of harm and to allow pharmacists to spend more time with patients instead of hunting for stock,” said NPA Policy Manager Helga Mangion.

More For You

UK "medicines market is fundamentally broken

Drug manufacturers have seen a sharp rise in the money they have to pay the NHS

Pic credit: iStock

UK "medicines market is fundamentally broken,” says industry leadership group

The UK government have been accused of putting off investors in drug manufacturing over the “unsustainable levy” companies are having to pay the NHS.

Industry leaders have warned that the government’s growth plan will not succeed unless ministers commit to fixing a scheme which now requires companies to make record payments up to a quarter to a third (23.5 per cent-35.6 per cent) of a company’s revenue from sales of branded medicines to the NHS.

Keep ReadingShow less
Listeria outbreak: Cool Delight Desserts products removed from health care setting

The bacteria were detected in chocolate and vanilla and strawberry and vanilla flavoured mousse.

Cool Delight Desserts

3 deaths linked to listeria outbreak; NHS staff advised to withdraw Cool Delight Desserts products

NHS staff have been advised to remove all Cool Delight Desserts products from service and sales as a precautionary measure following the death of three people linked to a listeria outbreak.

The UK Health Security Agency (UKHSA) and Food Standards Agency (FSA) are investigating five cases of Listeria monocytogenes infection linked to the same strain of bacteria found in mousses supplied to NHS hospitals and care homes.

Keep ReadingShow less
Impact of National Insurance rise on community pharmacies.

Pharmacies are faced with higher NI payments

Pic credit: Istock

Pharmacies to pay higher national insurance contributions after MPs refuse to back amendments to bill


Community pharmacies are faced with paying the higher rate of national insurance contributions that come into force next month after MPs on Wednesday (19) rejected amendments to a bill that was approved by the House of Lords.

Keep ReadingShow less
Novo Nordisk regains ABPI membership after two-year suspension

Novo Nordisk was suspended in March 2023 for sponsoring pharmacy weight management training courses.

Image Credit: Novo Nordisk

Novo Nordisk’s ABPI suspension lifted after two years

Novo Nordisk has regained full membership of the Association of the British Pharmaceutical Industry (ABPI) after a two-year suspension due to serious breaches of the ABPI Code of Practice.

The reinstatement follows rigorous audits of the company’s compliance procedures and governance by the Prescription Medicines Code of Practice Authority (PMCPA).

Keep ReadingShow less
NICE calls for annual BMI checks for adults with long-term conditions

Annual BMI measurements create early intervention opportunities for weight management

Getty Images

NICE seeks feedback on annual BMI checks for adults with long-term conditions

The National Institute for Health and Care Excellence (NICE) has published a draft quality standard recommending annual Body mass index (BMI) and waist-to-height measurements for adults with long-term conditions to help prevent weight-related complications.

A consultation has been launched to gather feedback from healthcare professionals and commissioners on the feasibility of implementing these proposals within the NHS.

Keep ReadingShow less